Latest Breaking News On - Enteric coated oral cepharanthine - Page 2 : comparemela.com

PharmaDrug Inc : PharmaDrug s Sairiyo Successfully Demonstrates Ability to Manufacture Cepharanthine (PD-001) for Human Clinical Studies

PharmaDrug Inc : PharmaDrug s Sairiyo Successfully Demonstrates Ability to Manufacture Cepharanthine (PD-001) for Human Clinical Studies
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesStefan klotterRobertj steenRobert steenGenvion corporationPharmadrug incPharmather holdings ltdNewsfile corpSecuredose synthetics incDrug administrationSairiyo therapeutics incAustralia therapeutic goods administrationSairiyo therapeuticsTherapeutic goods administrationDrug productEnteric coated oral cepharanthine

PharmaDrug Inc : PharmaDrug Announces Plans for First-In-Human Clinical Study with PD-001 (Enteric-Coated Cepharanthine -2HCL) in Esophageal Cancer

Toronto, Ontario (Newsfile Corp. - February 13, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development

United statesWangy cepharanthineDaniel cohenPharmadrug incDrug administrationNational cancer institute surveillanceNewsfile corpAustralia therapeutic goods administrationAustralia researchGenvion corporationAmerican cancer societyTherapeutic goods administrationEnteric coated oral cepharanthineValidated studies reveal potentialEnabling esophageal cancerSairiyo therapeutics

PharmaDrug Inc : PharmaDrug Advances Programs in Oncology with Filing of PCT Application Detailing the Use of PD-001 for Treatment of Prostate Cancer

Toronto, Ontario (Newsfile Corp. - January 31, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development

United statesWangy cepharanthineDaniel cohenBaillyc cepharanthineNewsfile corpDevelopment paths for oncologyPharmadrug incDrug administrationPatent cooperation treatySet forthCentered around demonstrated benefitPre clinical prostate cancerProvisional patentValidated studies support potentialDevelopment pathsInfectious disease create

PharmaDrug Advances Programs in Oncology and Infectious Disease through Completion of cGMP Drug Substance Manufacturing

Toronto - PharmaDrug Inc. , a specialty pharmaceutical company focused on the research, development and commercialization of psychedelics and other naturally-derived approved drugs, is pleased to. | October 5, 2022

United statesDaniel cohenDevelopment paths for oncologyPharmadrug incDrug administrationGenvion corporationDevelopment pathsInfectious disease createEnteric coated oral cepharanthineValidated studies reveal potentialEnabling prostate cancerProvisional patentSairiyo therapeuticsSuper smartNews publishingPharmadrug inc stock exchange

PharmaDrug Advances Programs in Oncology and Infectious Disease Through Completion of cGMP Drug Substance Manufacturing

PharmaDrug Advances Programs in Oncology and Infectious Disease Through Completion of cGMP Drug Substance Manufacturing
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSouth africaJapan generalSouth africanWangy cepharanthineDaniel cohenBaillyc cepharanthineNewsfile corpDevelopment paths for oncologyPharmadrug incDrug administrationGenvion corporationDevelopment pathsInfectious disease createEnteric coated oral cepharanthineValidated studies reveal potential